OHI Maintained at Sector Perform by Scotiabank, May 2026

Scotiabank maintained its Sector Perform rating on Omega Healthcare Investors (OHI) on May 21, 2026, while raising its price target to $50 from $48. The healthcare REIT trades at $48.26, reflecting modest weakness in the broader market. This OHI analyst rating keeps the stock in neutral territory despite the upward target revision. Meyka AI rates OHI with a grade of B+, reflecting solid fundamentals in the healthcare real estate sector.

Scotiabank Maintains OHI Analyst Rating with Higher Target

Scotiabank’s decision to hold its OHI analyst rating at Sector Perform signals confidence in the company’s long-term positioning. The $2 price target increase reflects improving operational metrics within Omega’s portfolio of skilled nursing and assisted living facilities.

The stock trades above its 50-day average of $46.36 and 200-day average of $44.19, showing resilience despite recent market headwinds. Omega’s $14.4 billion market cap positions it as a significant player in healthcare real estate.

Financial Metrics Show Strong Income Generation

Omega delivers a 5.55% dividend yield, making it attractive for income-focused investors seeking stable returns. The company’s P/E ratio of 23.31 reflects a reasonable valuation for a mature REIT with consistent cash flows.

OHI generated $3.08 in operating cash flow per share and $3.05 in free cash flow per share, demonstrating solid operational efficiency. These metrics underscore why Scotiabank raised its price target despite maintaining the neutral rating.

Analyst Consensus Leans Bullish on Healthcare REIT

Wall Street shows a Buy consensus with 12 analysts rating OHI as Buy and 8 recommending Hold. No analysts rate the stock as Sell, indicating broad confidence in the healthcare REIT sector.

Meyka AI’s proprietary analysis factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ grade reflects strong fundamentals, though valuation concerns limit upside potential in the near term.

Growth Trajectory and Dividend Sustainability

Omega posted 45% net income growth in fiscal 2025, driven by operational improvements across its facility portfolio. The company’s $2.68 dividend per share remains well-supported by cash generation, though the payout ratio exceeds 100%, typical for REITs.

Forecast models suggest OHI could reach $60.69 within three years and $72.53 within five years, assuming continued sector stability and operational execution.

Final Thoughts

Scotiabank’s maintained OHI analyst rating with an elevated price target reflects confidence in Omega Healthcare’s dividend sustainability and portfolio quality. The $50 target implies modest upside from current levels, though the Sector Perform rating suggests limited near-term catalysts. Investors seeking healthcare real estate exposure with a strong dividend yield will find OHI’s 5.55% payout compelling. The B+ Meyka grade and bullish analyst consensus support a hold-and-collect strategy for income investors. These grades are not guaranteed and we are not financial advisors.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.